Nuclear Medicine-EMEA Market Status and Trend Report 2013-2023
Report Summary
Nuclear Medicine-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Nuclear Medicine industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
EMEA Nuclear Medicine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Nuclear Medicine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
EMEA Nuclear Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
SPECT
PET
EMEA Nuclear Medicine Market: Players Segment Analysis (Company and Product introduction, Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare
Philips Healthcare
Siemens Healthcare
Toshiba
Hitachi
Carestream
Esaote
Shimadzu
TriFoil Imaging
Biosensors International Group, Ltd
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Nuclear Medicine-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Nuclear Medicine industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
- Whole EMEA and Regional Market Size of Nuclear Medicine 2013-2017, and development forecast 2018-2023
- Main market players of Nuclear Medicine in EMEA, with company and product introduction, position in the Nuclear Medicine market
- Market status and development trend of Nuclear Medicine by types and applications
- Cost and profit status of Nuclear Medicine, and marketing status
- Market growth drivers and challenges
EMEA Nuclear Medicine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Nuclear Medicine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
EMEA Nuclear Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
SPECT
PET
EMEA Nuclear Medicine Market: Players Segment Analysis (Company and Product introduction, Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare
Philips Healthcare
Siemens Healthcare
Toshiba
Hitachi
Carestream
Esaote
Shimadzu
TriFoil Imaging
Biosensors International Group, Ltd
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NUCLEAR MEDICINE
1.1 Definition of Nuclear Medicine in This Report
1.2 Commercial Types of Nuclear Medicine
1.2.1 SPECT Radiopharmaceuticals
1.2.2 PET Radiopharmaceuticals
1.3 Downstream Application of Nuclear Medicine
1.3.1 SPECT
1.3.2 PET
1.4 Development History of Nuclear Medicine
1.5 Market Status and Trend of Nuclear Medicine 2013-2023
1.5.1 EMEA Nuclear Medicine Market Status and Trend 2013-2023
1.5.2 Regional Nuclear Medicine Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Nuclear Medicine in EMEA 2013-2017
2.2 Consumption Market of Nuclear Medicine in EMEA by Regions
2.2.1 Consumption Volume of Nuclear Medicine in EMEA by Regions
2.2.2 Revenue of Nuclear Medicine in EMEA by Regions
2.3 Market Analysis of Nuclear Medicine in EMEA by Regions
2.3.1 Market Analysis of Nuclear Medicine in Europe 2013-2017
2.3.2 Market Analysis of Nuclear Medicine in Middle East 2013-2017
2.3.3 Market Analysis of Nuclear Medicine in Africa 2013-2017
2.4 Market Development Forecast of Nuclear Medicine in EMEA 2018-2023
2.4.1 Market Development Forecast of Nuclear Medicine in EMEA 2018-2023
2.4.2 Market Development Forecast of Nuclear Medicine by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Nuclear Medicine in EMEA by Types
3.1.2 Revenue of Nuclear Medicine in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Nuclear Medicine in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Nuclear Medicine in EMEA by Downstream Industry
4.2 Demand Volume of Nuclear Medicine by Downstream Industry in Major Countries
4.2.1 Demand Volume of Nuclear Medicine by Downstream Industry in Europe
4.2.2 Demand Volume of Nuclear Medicine by Downstream Industry in Middle East
4.2.3 Demand Volume of Nuclear Medicine by Downstream Industry in Africa
4.3 Market Forecast of Nuclear Medicine in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NUCLEAR MEDICINE
5.1 EMEA Economy Situation and Trend Overview
5.2 Nuclear Medicine Downstream Industry Situation and Trend Overview
CHAPTER 6 NUCLEAR MEDICINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Nuclear Medicine in EMEA by Major Players
6.2 Revenue of Nuclear Medicine in EMEA by Major Players
6.3 Basic Information of Nuclear Medicine by Major Players
6.3.1 Headquarters Location and Established Time of Nuclear Medicine Major Players
6.3.2 Employees and Revenue Level of Nuclear Medicine Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NUCLEAR MEDICINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GE Healthcare
7.1.1 Company profile
7.1.2 Representative Nuclear Medicine Product
7.1.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare
7.2 Philips Healthcare
7.2.1 Company profile
7.2.2 Representative Nuclear Medicine Product
7.2.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Philips Healthcare
7.3 Siemens Healthcare
7.3.1 Company profile
7.3.2 Representative Nuclear Medicine Product
7.3.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.4 Toshiba
7.4.1 Company profile
7.4.2 Representative Nuclear Medicine Product
7.4.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Toshiba
7.5 Hitachi
7.5.1 Company profile
7.5.2 Representative Nuclear Medicine Product
7.5.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Hitachi
7.6 Carestream
7.6.1 Company profile
7.6.2 Representative Nuclear Medicine Product
7.6.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Carestream
7.7 Esaote
7.7.1 Company profile
7.7.2 Representative Nuclear Medicine Product
7.7.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Esaote
7.8 Shimadzu
7.8.1 Company profile
7.8.2 Representative Nuclear Medicine Product
7.8.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Shimadzu
7.9 TriFoil Imaging
7.9.1 Company profile
7.9.2 Representative Nuclear Medicine Product
7.9.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of TriFoil Imaging
7.10 Biosensors International Group, Ltd
7.10.1 Company profile
7.10.2 Representative Nuclear Medicine Product
7.10.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Biosensors International Group, Ltd
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NUCLEAR MEDICINE
8.1 Industry Chain of Nuclear Medicine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NUCLEAR MEDICINE
9.1 Cost Structure Analysis of Nuclear Medicine
9.2 Raw Materials Cost Analysis of Nuclear Medicine
9.3 Labor Cost Analysis of Nuclear Medicine
9.4 Manufacturing Expenses Analysis of Nuclear Medicine
CHAPTER 10 MARKETING STATUS ANALYSIS OF NUCLEAR MEDICINE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Nuclear Medicine in This Report
1.2 Commercial Types of Nuclear Medicine
1.2.1 SPECT Radiopharmaceuticals
1.2.2 PET Radiopharmaceuticals
1.3 Downstream Application of Nuclear Medicine
1.3.1 SPECT
1.3.2 PET
1.4 Development History of Nuclear Medicine
1.5 Market Status and Trend of Nuclear Medicine 2013-2023
1.5.1 EMEA Nuclear Medicine Market Status and Trend 2013-2023
1.5.2 Regional Nuclear Medicine Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Nuclear Medicine in EMEA 2013-2017
2.2 Consumption Market of Nuclear Medicine in EMEA by Regions
2.2.1 Consumption Volume of Nuclear Medicine in EMEA by Regions
2.2.2 Revenue of Nuclear Medicine in EMEA by Regions
2.3 Market Analysis of Nuclear Medicine in EMEA by Regions
2.3.1 Market Analysis of Nuclear Medicine in Europe 2013-2017
2.3.2 Market Analysis of Nuclear Medicine in Middle East 2013-2017
2.3.3 Market Analysis of Nuclear Medicine in Africa 2013-2017
2.4 Market Development Forecast of Nuclear Medicine in EMEA 2018-2023
2.4.1 Market Development Forecast of Nuclear Medicine in EMEA 2018-2023
2.4.2 Market Development Forecast of Nuclear Medicine by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Nuclear Medicine in EMEA by Types
3.1.2 Revenue of Nuclear Medicine in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Nuclear Medicine in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Nuclear Medicine in EMEA by Downstream Industry
4.2 Demand Volume of Nuclear Medicine by Downstream Industry in Major Countries
4.2.1 Demand Volume of Nuclear Medicine by Downstream Industry in Europe
4.2.2 Demand Volume of Nuclear Medicine by Downstream Industry in Middle East
4.2.3 Demand Volume of Nuclear Medicine by Downstream Industry in Africa
4.3 Market Forecast of Nuclear Medicine in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NUCLEAR MEDICINE
5.1 EMEA Economy Situation and Trend Overview
5.2 Nuclear Medicine Downstream Industry Situation and Trend Overview
CHAPTER 6 NUCLEAR MEDICINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Nuclear Medicine in EMEA by Major Players
6.2 Revenue of Nuclear Medicine in EMEA by Major Players
6.3 Basic Information of Nuclear Medicine by Major Players
6.3.1 Headquarters Location and Established Time of Nuclear Medicine Major Players
6.3.2 Employees and Revenue Level of Nuclear Medicine Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NUCLEAR MEDICINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GE Healthcare
7.1.1 Company profile
7.1.2 Representative Nuclear Medicine Product
7.1.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare
7.2 Philips Healthcare
7.2.1 Company profile
7.2.2 Representative Nuclear Medicine Product
7.2.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Philips Healthcare
7.3 Siemens Healthcare
7.3.1 Company profile
7.3.2 Representative Nuclear Medicine Product
7.3.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.4 Toshiba
7.4.1 Company profile
7.4.2 Representative Nuclear Medicine Product
7.4.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Toshiba
7.5 Hitachi
7.5.1 Company profile
7.5.2 Representative Nuclear Medicine Product
7.5.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Hitachi
7.6 Carestream
7.6.1 Company profile
7.6.2 Representative Nuclear Medicine Product
7.6.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Carestream
7.7 Esaote
7.7.1 Company profile
7.7.2 Representative Nuclear Medicine Product
7.7.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Esaote
7.8 Shimadzu
7.8.1 Company profile
7.8.2 Representative Nuclear Medicine Product
7.8.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Shimadzu
7.9 TriFoil Imaging
7.9.1 Company profile
7.9.2 Representative Nuclear Medicine Product
7.9.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of TriFoil Imaging
7.10 Biosensors International Group, Ltd
7.10.1 Company profile
7.10.2 Representative Nuclear Medicine Product
7.10.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Biosensors International Group, Ltd
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NUCLEAR MEDICINE
8.1 Industry Chain of Nuclear Medicine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NUCLEAR MEDICINE
9.1 Cost Structure Analysis of Nuclear Medicine
9.2 Raw Materials Cost Analysis of Nuclear Medicine
9.3 Labor Cost Analysis of Nuclear Medicine
9.4 Manufacturing Expenses Analysis of Nuclear Medicine
CHAPTER 10 MARKETING STATUS ANALYSIS OF NUCLEAR MEDICINE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
